Lipid A Biosynthesis of Multidrug-Resistant Pathogens - A Novel Drug Target

E-ISSN： 1873-4286|19|36|6534-6550

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.36, 2013-11, pp. : 6534-6550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid Membrane; A Novel Target for Viral and Bacterial Pathogens

Current Drug Targets, Vol. 7, Iss. 12, 2006-12 ,pp. : 1615-1621

Bentham Science Publishers

Access to resources Recommend Favorite

Current review of antimicrobial treatment of nosocomial pneumonia caused by multidrug-resistant pathogens

By Jean Shio-Shin Hsueh Po-Ren

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2145-2148

Informa Healthcare

Access to resources Recommend Favorite

P-glycoprotein as a Drug Target in the Treatment of Multidrug Resistant Cancer

Current Drug Targets, Vol. 1, Iss. 1, 2000-07 ,pp. : 85-99

Bentham Science Publishers

Access to resources Recommend Favorite

Analysis of Drug Transport Kinetics in Multidrug-resistant Cells: Implications for Drug Action

Current Medicinal Chemistry, Vol. 8, Iss. 1, 2001-01 ,pp. : 51-64

Bentham Science Publishers

Access to resources Recommend Favorite

Multidrug-resistant TB gets backing from drug giant

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 416, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite